dc.contributor.author | Tachezy, Ruth | |
dc.contributor.editor | Šímová, Šárka | |
dc.date.issued | 2022 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14178/1779 | |
dc.description.abstract | The group is composed of the team of Laboratory of Molecular and Tumor Virology (headed by Ruth Tachezy) and Laboratory of Immunotherapy (headed by Michal Šmahel). While the research of the team led by Ruth Tachezy focuses mainly on the molecular epidemiology of anelloviruses, polyomaviruses, herspesviruses, and papillomaviruses with the aim of evaluating the involvement of these viruses in different benign and malignant disorders, the research of the group of Michal Šmahel is focused on the optimization of combined cancer immunotherapy. The research of both teams complements each other. Finding the association of viruses with particular disorders opens the possibility of searching for diagnostic, therapeutic, preventive, and prognostic markers of these diseases. Therapeutic markers are being further explored in both in vitro and in vivo model systems and combined immunotherapy is further evaluated | en |
dc.language.iso | en | |
dc.relation.url | http://www.ccsss.cz/index.php/ccsss/issue/view/37 | |
dc.rights | Tento výsledek je zpřístupněn v režimu gratis open access, tj. pouze pro čtení. V souladu s § 30 zákona č. 121/2000 Sb., autorského zákona, lze plný text z repozitáře také stáhnout, případně vytisknout, ale pouze pro osobní potřebu. | cs |
dc.rights | The fulltext is published in the repository as read-only, i.e. in gratis open access mode. Repository visitors are entitled to download and print the fulltext published without a licence for their personal use only (in accordance with § 30 of Act No. 121/2000 Coll., the Copyright Act). | en |
dc.title | Group of cancer immunotherapy and molecular epidemiology of virus infections | en |
dcterms.accessRights | openAccess | |
dc.date.updated | 2023-10-02T06:14:56Z | |
dc.subject.keyword | HPV | en |
dc.subject.keyword | tumor microenvironment | en |
dc.subject.keyword | immunotherapy | en |
dc.publisher.publicationPlace | Praha | |
dc.relation.fundingReference | info:eu-repo/grantAgreement/MSM//LX22NPO5103 | |
dc.date.embargoStartDate | 2023-10-02 | |
dc.type.obd | 110 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | |
dc.identifier.obd | 622214 | |
dc.identifier.riv | RIV/00216208:11310/22:10454555 | |
dc.subject.rivPrimary | 10000::10600::10607 | |
dcterms.isPartOf.name | Czech Chemical Society Symposium Series | |
dcterms.isPartOf.issn | 2336-7202 | |
dcterms.isPartOf.journalYear | 2022 | |
dcterms.isPartOf.journalVolume | 20 | |
dcterms.isPartOf.journalIssue | 6 | |
uk.faculty.primaryId | 115 | |
uk.faculty.primaryName | Přírodovědecká fakulta | cs |
uk.faculty.primaryName | Faculty of Science | en |
uk.department.primaryId | 1034 | |
uk.department.primaryName | Katedra genetiky a mikrobiologie | cs |
uk.department.primaryName | Department of Genetics and Microbiology | en |
uk.event.name | The first annual meeting of the National Institute of Virology and Bacteriology (NIVB Meeting 2022) | |
dc.description.pageRange | 392-392 | |
dc.type.obdHierarchyCs | ABSTRAKT::abstrakt::abstrakt v konferenčním sborníku | cs |
dc.type.obdHierarchyEn | ABSTRACT::abstract::abstract in conference proceedings | en |
dc.type.obdHierarchyCode | 110::130::462 | en |
uk.displayTitle | Group of cancer immunotherapy and molecular epidemiology of virus infections | en |